Like all medications, they come with potential side effectsmost commonly nausea, vomiting, and gastrointestinal discomfort
Across multiple national and multinational healthcare databases, GLP-1 use was associated with lower rates of colorectal cancer compared with non-use and with other antidiabetic therapies, including insulin and sulfonylureas
UK prescribers working with existing GLP-1 and dual agonist therapies generally advise patients to: Choose a consistent day of the week for injection and set a reminder Document the time and site of each injection in a diary or app Report any unexpected or worsening symptoms promptly to their GP, specialist, or trial team Not adjust the dose independently dose escalation should always be supervised If you are considering joining a clinical trial involving retatrutide, NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) is the current UK service for identifying registered clinical studies and is the recommended starting point for patients
This article reviews the most frequently asked questions about tirzepatide and menstrual health
Bladeren, Consumption of brussels sprouts results in elevated a-class glutathione s-transferase levels in human blood plasma, Carcinogenesis , vol